An anti-mouse PD-L1 antibody (200 μg/mouse, clone B7-H1, BioXCell) was injected through the intraperitoneal cavity of tumor-bearing mice on days 2 and 4 after the injection of murine ovarian cancer cells. This evidence concerns the gene CD274 and ovarian carcinoma.